RC

Riccardo Canevari

Radiopharm Theranostics Limited | Chief Executive Officer, Managing Director
Mr Canevari has been our Chief Executive Officer and Managing Director since September 2021. He was previously Chief Commercial Officer of Novartis company, Advanced Accelerator Applications. Prior to that, he was Senior Vice President and Global Head of the Breast Cancer Franchise for Novartis Oncology from 2017. He has also held various management roles with Novartis Pharma and Ethicon/Johnson & Johnson.

Company and Roles

Company
Title
Tenure
Since
RAD
RAD
Radiopharm Theranostics Limited
  • Chief Executive Officer
  • Managing Director
4yrs, 10mthSep 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
RAD
Radiopharm Theranostics Limited
12/12/2520,029,9862,650,000185,287,299N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
RAD
Radiopharm Theranostics Limited
12/12/25
Issued
74,338,000$0.019$1,412,422Issue of options
RAD
RAD
Radiopharm Theranostics Limited
30/10/25
Buy
1,500,000$0.025$37,500On-market trade
RAD
RAD
Radiopharm Theranostics Limited
16/12/24
Issued
7,091,615$0.031$219,840As advised by the company
RAD
RAD
Radiopharm Theranostics Limited
16/12/24
Buy
684,787$0.029$19,858On-market trade
RAD
RAD
Radiopharm Theranostics Limited
16/12/24
Issued
55,250,286$0.027$1,491,757Issue of options